Evaluation of the Transversus abdominis plane block (TAP-block) in preventing painful urine bladder spam in patients undergoing Robot Assisted Laparoscopic Radical Prostatectomy under general anesthesia, a prospective randomized controlled trial

Evaluation of the Transversus abdominis plane block (TAP-block) in preventing painful urine bladder spam in patients undergoing Robot Assisted Laparoscopic Radical Prostatectomy under general anesthesia, a prospective randomized controlled trial - TAP in RALP

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON31036

Enrollment

100

Registered

2007-10-15

Start date

2008-04-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bladder spasm

Interventions

A bilateral TAP-block is performed in patients undergoing a RALP for prostate cancer, randomized for TAP-block.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Men with prostate cancer scheduled for robot assisted laparoscopic radical prostatectomy (RALP)

Exclusion criteria

Exclusion criteria: Mental disorders. Inability to communicate in Dutch or English language Re-intervention procedures after (RALP) Conversion form RALP to an open procedure Allergy for amide type local anesthetic agents Allergy for oxybutinine, or butylscopolamine Allergy to acetaminophen Allergy to diclofenac.

Design outcomes

Primary

Measure	Time frame
The incidence rate of postoperative bladder spasm at 1 hour after arrival at the recovery room , 4 hours postoperatively and on the morning of the first postoperative day.	—

Secondary

Measure	Time frame
Pain by NRS (0 - 10) , done one hour after arrival at the recovery room , 4 hours postoperatively and on morning of the first postoperative day. Postoperative nausea and vomiting during the period end of the surgical procedure till 12:00 am of the first postoperative day. The cumulative dose of oxybutinine and butylscopolamine and morfine given between the arrival at the recovery room and 12 am on the morning of the first postoperative day.	—

Measure

Time frame

Pain by NRS (0 - 10) , done one hour after arrival at the recovery room , 4 hours postoperatively and on morning of the first postoperative day. Postoperative nausea and vomiting during the period end of the surgical procedure till 12:00 am of the first postoperative day. The cumulative dose of oxybutinine and butylscopolamine and morfine given between the arrival at the recovery room and 12 am on the morning of the first postoperative day.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)